While PD-1 blockade improves LCMV specific immune control by CD8+ T cells during acute infection [38], we demonstrate that PD-1 positive CD8+ T cell populations retain functionality and proliferative capacity during primary symptomatic EBV infection. This evidence concerns the gene CD8A and Epstein-Barr virus infection.